Evaluation of the care of patients living with HIV/AIDS under antiretroviral treatment at the Matam Communal Medical Center in Conakry (2021-2023)

Introduction: Biological and therapeutic monitoring of patients living with HIV (PLHIV) are important, particularly in areas where morbidity and mortality are high. 

Objective: To assess the current situation of care and the hematological profile of PLHIV on antiretroviral treatment at the Matam Communal Medical Center. 

Material and Methods: Two years’ prospective study, October 1^st, 2021 to October 31^st, 2023. 

Results: A total of 203 patients were studied. females were predominant (67.49%) with a sex ratio = 2.07. The majority of patients were in the 21-40 age group (44.82%), followed by 41-60 years (39.90%). The average age of the patients was 39 years with extremes of 18 and 76 years. Singles represented 65.02%, followed by divorced (19.21%) and married (15.27%). On the socio-professional level, housewives were the majority (33.49%), followed by workers (30.04%), and sales agents (23.64%). Amongst the 81 patients tested to their viral load, 70% had a detectable viral load. Immunodeficiency was generally advanced. The majority of patients had a LTCD4+ rate below 200Cells/µl. The mean LTCD4+ level was 124.52 cells/µl with a range of 5 to 349 cells/µl. Out of 203 PLHIV, 53% had a low hemoglobin level (mean 9.86g/dl). Out of 107 PLHIV/AIDS, the different types of anemia were observed: microcytic anemia (20.56%), normocytic anemia (79.43%), hypochromic anemia (30.84%), low hematocrit (71%), low leukocyte count (65.42%), low neutrophil count (40.18%), lymphocytes (60.74%), monocytes (54.20%), platelets (31.77%). 

Conclusion: Viral load and hematological profile of PLHIV/AIDS were determined to improve the management PLHIV, and to avoid antiviral therapeutic failures.